Nichols William Garrett — SEC Form 4 filings
SEC reporting owner CIK 1618364. 10 Form 4 filings on record with FilingPulse; latest filed 2026-01-28.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-07-15 to 2026-01-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 8 filings — 102,840 shares, $763,790 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 45,316 shares @ $8.76 ($396,995) in Candel Therapeutics, Inc., filed 2025-03-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | Chief Medical Officer | 10 | — | 8 legs · 102,840 sh · $763,790 | 10 |
Form 4 filings — Nichols William Garrett
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-28 | 4 | Candel Therapeutics, Inc. (CADL) | Grant/award (A): 136,500 (derivative) @ $0 | EDGAR |
| 2025-07-30 | 4 | Candel Therapeutics, Inc. (CADL) | Option exercise (M): 937 @ $1.29 · Sale (S): 937 @ $6.98 · Option exercise (M): 937 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Candel Therapeutics, Inc. (CADL) | Option exercise (M): 781 @ $1.29 · Sale (S): 781 @ $5.04 · Option exercise (M): 781 (derivative) @ $0 | EDGAR |
| 2025-03-20 | 4 | Candel Therapeutics, Inc. (CADL) | Option exercise (M): 4,584 @ $3.75 · Option exercise (M): 13,905 @ $1.29 · Sale (S): 45,316 @ $8.76 · Option exercise (M): 4,584 (derivative) @ $0 · Option exercise (M): 13,905 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Candel Therapeutics, Inc. (CADL) | Grant/award (A): 107,250 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Candel Therapeutics, Inc. (CADL) | Sale (S): 10,428 @ $7.22 | EDGAR |
| 2025-01-10 | 4 | Candel Therapeutics, Inc. (CADL) | Sale (S): 10,799 @ $8.22 | EDGAR |
| 2024-12-03 | 4 | Candel Therapeutics, Inc. (CADL) | Sale (S): 13,935 @ $4.56 | EDGAR |
| 2024-07-19 | 4 | Candel Therapeutics, Inc. (CADL) | Sale (S): 10,875 @ $6.47 | EDGAR |
| 2024-07-15 | 4 | Candel Therapeutics, Inc. (CADL) | Sale (S): 9,769 @ $5.97 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1618364 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →